These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23169439)

  • 1. Synthesis of a new pH-sensitive folate-doxorubicin conjugate and its antitumor activity in vitro.
    Ye WL; Teng ZH; Liu DZ; Cui H; Liu M; Cheng Y; Yang TH; Mei QB; Zhou SY
    J Pharm Sci; 2013 Feb; 102(2):530-40. PubMed ID: 23169439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Anti-Tumor Effect of Folate-Targeted FA-AMA-hyd-DOX Conjugate in a Xenograft Model of Human Breast Cancer.
    Liao TT; Han JF; Zhang FY; Na R; Ye WL
    Molecules; 2021 Nov; 26(23):. PubMed ID: 34885691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer activity of released doxorubicin from a folate-mediated polyelectrolyte complex.
    Chiu CC; Lin YT; Sun SL; Sung KH; Wang LF
    J Biomater Sci Polym Ed; 2011; 22(11):1487-507. PubMed ID: 20626956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W; Zhou J; Mann A; Wang Y; Zhu L
    Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticles.
    Ye WL; Du JB; Zhang BL; Na R; Song YF; Mei QB; Zhao MG; Zhou SY
    PLoS One; 2014; 9(5):e97358. PubMed ID: 24828815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folate/N-acetyl glucosamine conjugated mesoporous silica nanoparticles for targeting breast cancer cells: A comparative study.
    Kumar P; Tambe P; Paknikar KM; Gajbhiye V
    Colloids Surf B Biointerfaces; 2017 Aug; 156():203-212. PubMed ID: 28531877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery.
    Zhang H; Li F; Yi J; Gu C; Fan L; Qiao Y; Tao Y; Cheng C; Wu H
    Eur J Pharm Sci; 2011 Apr; 42(5):517-26. PubMed ID: 21352909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
    Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
    Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
    Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
    Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of surface functionalized hydroxyapatite nanoparticles for enhanced specificity towards tumor cells.
    Verma G; Shetake NG; Pandrekar S; Pandey BN; Hassan PA; Priyadarsini KI
    Eur J Pharm Sci; 2020 Mar; 144():105206. PubMed ID: 31870813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
    Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
    Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin nanospheres.
    Shen Z; Li Y; Kohama K; Oneill B; Bi J
    Pharmacol Res; 2011 Jan; 63(1):51-8. PubMed ID: 21035550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
    Mizusako H; Tagami T; Hattori K; Ozeki T
    J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging.
    Yang X; Grailer JJ; Rowland IJ; Javadi A; Hurley SA; Matson VZ; Steeber DA; Gong S
    ACS Nano; 2010 Nov; 4(11):6805-17. PubMed ID: 20958084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatment.
    Yin JJ; Sharma S; Shumyak SP; Wang ZX; Zhou ZW; Zhang Y; Guo P; Li CZ; Kanwar JR; Yang T; Mohapatra SS; Liu W; Duan W; Wang JC; Li Q; Zhang X; Tan J; Jia L; Liang J; Wei MQ; Li X; Zhou SF
    PLoS One; 2013; 8(5):e62289. PubMed ID: 23658721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin loaded silica nanorattles actively seek tumors with improved anti-tumor effects.
    Gao F; Li L; Liu T; Hao N; Liu H; Tan L; Li H; Huang X; Peng B; Yan C; Yang L; Wu X; Chen D; Tang F
    Nanoscale; 2012 Jun; 4(11):3365-72. PubMed ID: 22538830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.